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Objectives: The present review investigated whether there are systematic sex differences in 
the placebo and the nocebo effect.
Methods: A literature search was conducted in multiple electronic databases. Studies were 
included if the study compared a group or condition where a placebo was administered to a 
natural history group or similar cohort.
Results: Eighteen studies were identified – 12 on placebo effects and 6 on nocebo effects. Chi-
square tests revealed that 1) males responded more strongly to placebo treatment, and females 
responded more strongly to nocebo treatment, and 2) males responded with larger placebo effects 
induced by verbal information, and females responded with larger nocebo effects induced by 
conditioning procedures.
Conclusion: This review indicates that there are sex differences in the placebo and nocebo 
effects, probably caused by sex differences in stress, anxiety, and the endogenous opioid system.
Keywords: placebo response, nocebo response, placebo analgesia, nocebo hyperalgesia, sex 
differences
Introduction
The placebo effect is a psychological and/or physiological response that follows 
administration of inert substances or treatments.1 For example, an inactive medication 
administered together with information that it is an analgesic medication has been 
found to decrease pain and pain-related physiological reactions.2 The nocebo effect is 
defined as increased pain or other symptoms after administration of an inactive treat-
ment purported to increase pain or unpleasant symptoms.3
Placebo and nocebo effects have mostly been studied in the field of pain, and 
sex differences in placebo analgesia4,5 and nocebo hyperalgesia3,6 have been reported 
repeatedly. There are sex differences in pain, with males often reporting lower pain 
to a standard stimulus.7 Furthermore, males often have a higher pain threshold8 and 
tolerance than females,9 and several pain conditions and pain-related symptoms are 
more frequent among females10,11 – for example, musculoskeletal pain12 and fibromy-
algia.13 Thus, because there are sex differences in experimental and clinical pain, we 
hypothesize that sex differences exist also in placebo and nocebo responses.
Sex differences in placebo and nocebo responses could be due to sex differences 
in the underlying psychological or physiological processes mediating placebo and 
nocebo effects. Placebo analgesia is partly due to activation of a descending pain-
modulatory system that involves endogenous opioid activation,14 and nocebo hyper-
algesia is partly mediated through activation of endogenous pronociceptive systems 
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involving cholecystokinin (CCK)15,16 and HPA hyperactiv-
ity.17 CCK has an inhibitory effect on placebo analgesia and 
an excitatory effect on nocebo hyperalgesia.16 Therefore, any 
sex differences in placebo and nocebo responses may reflect 
sex differences in these systems.
Endogenous pain modulation obtained by diffuse noxious 
inhibitory controls (DNICs) – where pain to one stimulus is 
reduced by application of a second painful stimulus – has 
been found to reduce pain more in males than in females.18 
Thus, data suggest that activation of endogenous pain modu-
lation reduces pain more in males than in females, which 
is consistent with stronger placebo analgesic responses in 
males compared to females. Stress-induced analgesia (SIA) 
is also mediated by activation of the descending inhibitory 
pain pathway, and SIA may take place during or following 
exposure to stress- or fear-inducing situations.19 Males exhibit 
stronger SIA than females,20 and animal studies have shown 
that SIA may be partially reversed by opioid blockade in 
males, but not in females.21
Aslaksen et al reported that placebos reduced stress 
more in males than in females, and, when controlling for 
the effect of stress, the sex differences in placebo analgesia 
disappeared.4 Thus, sex differences in placebo analgesia may 
be explained by sex differences in stress levels. Potential 
explanations are that there are sex differences in the pain 
modulatory system involving endogenous opioids and CCK 
as well as sex differences in stress responses.
Sex differences in placebo and nocebo responding have 
also been found in domains other than pain, such as in 
cognitive performance,22 dopaminergic function,23 nausea,24 
and mental distress.25 Thus, the observed sex differences 
in placebo and nocebo responding could also be due to 
sex differences in information processing. Klosterhalfen 
et al investigated differences in nocebo responding due to 
the induction method.24 The results revealed that females 
responded with larger nocebo responses than males when a 
conditioning procedure was used, whereas males responded 
with larger nocebo responses than females when a verbal 
procedure was used. All types of placebo and nocebo effects 
are mediated through the same psychological processes, 
namely through expectancies and/or via conditioning pro-
cedures. Therefore, the present study investigated whether 
there are sex differences in the placebo and the nocebo effect, 
and whether sex differences in the placebo and the nocebo 
effect are due to the induction method.
The present review hypothesized that 1) placebo 
responses would be stronger or more frequently observed in 
males than in females, 2) nocebo responses would be stronger 
or more frequently observed in females than in males, 3) 
verbally induced placebo responses would be more frequently 
observed in males than in females, and 4) conditioned nocebo 




Searches in the Medline, PsycINFO, Embase and ISI data-
bases (Web of Science) were conducted until July 29, 2016. 
“Sex” refers to biological differences between males and 
females. “Gender,” on the other hand, refers to socially cre-
ated differences between males and females. However, the 
terms have not been used consistently across studies, and 
both terms were included in the searches, although sex differ-
ences are the focus of this review. Two searches that included 
Boolean search terms were conducted in each of the chosen 
databases. One search was conducted for the placebo and 
nocebo effects, and one search was conducted for placebo 
analgesia and nocebo hyperalgesia (Table 1). A review pro-
tocol does not exist, but a list of the excluded articles can be 
forwarded by contacting the corresponding author (SMV).
Data extraction
One author (SMV) extracted data from the included stud-
ies. The other author (MAF) checked these data. The search 
resulted in 1,635 hits. Only studies with a natural history 
control group or condition were included, to ascertain that any 
changes in symptoms after placebo administration were pla-
cebo or nocebo effects. A placebo response was defined as the 
difference in the response in a condition where information 
was provided that effective treatment had been administered 
and the response in a condition where this information was 
not presented and symptoms were only monitored. Studies 
were excluded if a placebo response was defined only as 
the difference between a pretest and a posttest in the same 
Table 1 Search terms used in the literature search
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Sex differences in the placebo and nocebo effects
group. Studies which 1) included a group or condition where 
placebo was administered with information that the placebo 
had therapeutic effects and a natural history group or condi-
tion where no treatment was provided and the symptom was 
only observed, or 2) administered the same amount of drug 
to all participants, but where different types of information 
about the drug were provided to different groups or condi-
tions were included. Studies where the placebo response or 
the placebo effect was not the primary outcome were also 
included. Studies reporting significant sex differences in the 
placebo or the nocebo effect were included. Thus, “a larger 
effect,” henceforth, refers to significant sex differences in the 
placebo or the nocebo effect.
Included studies were categorized according to design, 
number of participants, healthy volunteers or patients, induc-
tion method, target disorder or symptom, and outcome. The 
induction method was differentiated into verbal information 
and conditioning. Conditioning as induction method was 
defined as placebo or nocebo treatments induced through 
1) response conditioning, for example, by surreptitiously 
reducing the intensity of a painful stimuli, or 2) response 
conditioning by social observational modeling.
Statistics
Chi-square tests were conducted to test the association 
between 1) placebo and nocebo effects and sex, and 2) induc-
tion method and sex.
Results
Eighteen studies satisfied the inclusion and exclusion crite-
ria. Further details about the identification, inclusion, and 
exclusion process are displayed in Figure 1. References for 
the included studies are presented in Box S1. Eight studies 
investigated placebo analgesia, and two studies investigated 
nocebo hyperalgesia. The remaining eight studies investi-
gated cognitive performance, mental distress, dopaminergic 
functioning, irritable bowel syndrome (IBS) symptoms, 
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Variables such as emotions and stress were included when 
they were relevant for the interpretation of the results. The 
studies are summarized in Table 2 and presented with full 
references in Appendix 1.
Among the 12 placebo studies, only males responded 
with a placebo effect, or with a larger placebo effect than 
females, in eight studies.
The association between sex and placebo and nocebo 
responding was significant (c2 [1, N=18], p=0.046), indi-
cating that more studies showed a placebo effect in males 
compared to females, and more studies showed a nocebo 
effect in females compared to males.
Additionally, the association between induction method 
and sex in placebo and nocebo responding was significant 
Table 2 included studies 











Pain Significantly larger nocebo 
hyperalgesic effect on pain report 
in females than in males
Aslaksen et al4 within 
subjects 
design




Pain Significant placebo effect on 
pain unpleasantness and the P2 
component in the eeG in males, 
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Flaten44
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Pain Significant placebo effect on pain 
intensity in males, but not in 
females
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Pain Placebo effect on heat pain 
threshold in boys and girls, but 











Pain Placebo effect on pain report 
in both males and females 
Significantly larger placebo effect 
on neural modulation in males 
compared to females
Colloca et al29 Between-
groups design




Pain Placebo response enhanced 
and cortisol levels decreased 
significantly by vasopressin in 





84 (42) Healthy 
volunteers
Conditioning Pain Nocebo effect in males and 
females, but significantly larger 
nocebo effect on pain report in 
females than in males
Oken et al22 Between-
groups design




Cognitive performance Significant placebo effect on 
choice reaction time in males, but 
not in females
Haltia et al23 within-
subjects 
design




Dopaminergic functioning Significant placebo effect on 
reported drug effect in females, 
but not in males
Kelley et al50 Between-
groups design




iBS symptoms Significantly larger placebo effect 








48 (24) Healthy 
volunteers
Conditioning Nausea Significant nocebo effect on 
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Sex differences in the placebo and nocebo effects
(c2 [1, N=18], p=0.023). Thus, verbal information induced 
placebo effects more frequently in males, whereas classical 
conditioning more frequently induced nocebo effects in 
females.
Discussion
The results showed that placebo responses were more 
often seen in males compared to females, whereas nocebo 
responses were more often observed in females than in males. 
Moreover, verbally induced placebo responses were more fre-
quent in males than in females, whereas conditioned nocebo 
responses were more frequent in females than in males. There 
are several potential explanations for these sex differences. 
In the following text, we argue that sex differences in pla-
cebo and nocebo responding are due to sex differences in 1) 
affective responses to placebo and nocebo treatment, and 2) 
underlying psychophysiological mechanisms.
Sex differences in the placebo effect
The finding that males displayed placebo responses more 
frequently than females may be due to sex differences in 
psychophysiological mechanisms involved in stress and 
anxiety. Increased negative emotions may induce increased 
pain26 and result in nocebo responding. Activation of endog-
enous pain modulatory processes by stress, as in SIA,19 or 
by DNIC18 have been reported to reduce pain more in males 
than in females. Both these procedures involve increased 
stress. Placebo analgesia, on the other hand, is partly due to 
decreased stress.4 The association between reduced stress and 
reduced pain report in males, but not in females, after placebo 
administration could suggest that males are more responsive 
to stress-related endogenous pain modulatory processes than 
females. McCubbin et al showed that the effect of relaxation 
training was blocked by administration of naloxone, indicat-
ing that the effect of relaxation training was mediated by 
opioids.27 Thus, opioids are activated by both increased and 
decreased stress. Koepp et al used positron emission tomog-
raphy and observed reduced binding of a μ-receptor agonist 
in subjects that experienced positive emotions.28 The finding 
indicated that positive emotions were related to increased 
opioid activity. Thus, decreased stress and increased positive 
emotions have been associated with increased opioid activity, 
and this could be part of the mechanism underlying placebo 
analgesia. Accordingly, sex differences in this mechanism 
may partly explain the sex differences in placebo responding 
reported in this review.
The finding that vasopressin enhances the magnitude of 
the placebo effect and decreases stress levels in females, but 
not in males,29 supports the hypothesis that sex differences in 
the placebo effect are explained by sex differences in stress 
and the underlying neurophysiological and neurobiologi-
cal mechanisms. Vasopressin is involved in processing and 
regulation of social behaviors, and it has been reported that 
males and females respond with different brain activation 
and behavior after vasopressin administration. Colloca et al29 
administered intranasal vasopressin as placebo treatment and 
Table 2 (Continued) 















Nausea Significant nocebo effect on 
rotation tolerance in males, but 
not in females
Faasse et al47 Between-
groups design
82 (51) Healthy 
volunteers
Conditioning Symptoms associated with 
intake of an inert medication 
(participants was informed 
that the medication was a 
beta-blocker, but in fact they 
received a placebo).
Significant nocebo effect on 
total reported symptoms 
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Conditioning Symptoms associated 
with inhalation of an 
inert environmental toxin 
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that the medication was a 
suspected environmental toxin, 
but, in fact, it was a placebo)
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uncovered that females with the lowest cortisol and anxi-
ety levels responded with the largest vasopressin-induced 
placebo effects. This suggests that high levels of stress and 
negative emotions in females are central for the explanation 
of sex differences in the placebo effect. Kessner et al included 
only males in a study investigating the effect of oxytocin 
on placebo analgesia and reported that oxytocin increased 
the placebo analgesic response in males.30 As vasopres-
sin, oxytocin is involved in regulation of social behaviors. 
Pharmacological interventions for investigating placebo and 
nocebo effects represent a novel and promising approach, 
also for the understanding of sex differences in placebo and 
nocebo effects.
Sex differences in the nocebo effect
The relationship between high levels of anxiety and high 
levels of pain is stronger in females than in males31,32 and 
may explain the observations that females respond more 
often and stronger to nocebo hyperalgesic treatment than 
males. Swider and Babel showed that social observational 
modeling induced larger nocebo hyperalgesic responses in 
females than in males and suggested that this difference was 
due to larger increases in anxiety in females than in males.6
Previous negative drug experiences may enhance nocebo 
responding. Liccardi et al investigated adverse reactions after 
oral administration of placebo in patients that previously had 
reported adverse reactions to different medications.33 It was 
found that adverse reactions to placebo were significantly 
more frequent in females compared to males. Ströhle inves-
tigated sex differences in responses to placebo and sodium 
lactate in patients diagnosed with panic disorder.34 Infusion 
of sodium lactate increases anxiety levels and may generate 
panic attacks in patients with panic disorder. Females diag-
nosed with panic disorder responded with higher anxiety to 
infusion of placebo, compared to males with panic disorder. 
However, the studies by Liccardi et al33 and Ströhle34 did not 
include a natural history control condition and only suggest 
that females display larger increases in anxiety after a nocebo 
has been administered, compared to males.
Sex differences in the placebo and nocebo 
effect due to the induction method
Klosterhalfen et al showed that females responded more 
strongly than males to conditioned stimuli, whereas males 
responded more strongly than females toward verbal sug-
gestions.24 This hypothesis fits well with findings from the 
present review. Activation of the endogenous opioid system 
mediates placebo analgesia, and naloxone inhibits or abol-
ishes placebo analgesic responses. However, naloxone does 
not reduce all types of placebo responses. Therefore, not 
all placebo responses are mediated through the endogenous 
opioid system. Amanzio and Benedetti reported that placebo 
analgesia induced by verbal information was reduced by 
naloxone, and that placebo analgesia induced by classical 
conditioning was naloxone-insensitive if the previously 
administered drug was non-opioid.35 This suggests that 
verbally induced placebo responses are mediated by the 
endogenous opioid system, whereas conditioned placebo 
responses are mediated by other mechanisms. Thus, the 
stronger verbally induced placebo responses in males may be 
due to a more effective endogenous opioid system in males, 
compared to females.
An alternative hypothesis for the sex differences in 
nocebo responses is that adverse drug reactions (nocebo 
responses) may be a form of compensatory conditioned 
response,36 but there is no evidence that these are stronger in 
females.37 Developing a method for measuring information 
processing in the context of placebo effects may be valuable 
for future investigations of sex differences. Knowledge of 
how previous experiences with medications or treatments 
influence the placebo effect in males and females could 
 contribute to the understanding of the observed sex dif-
ferences in placebo responding. It is suggested that future 
studies report previous experience with medications or 
treatments.
A recent meta-analysis that included randomized 
controlled trials on psychiatric treatment found no sex dif-
ferences in the placebo arm of these trials.38 However, the 
included studies lacked a natural history group. Thus, as 
several processes other than expectations could be acting in 
those control groups, that meta-analysis is not relevant for 
the present review. Although performing a meta-analysis had 
been preferable in the present study, the required data were 
not reported in several of the included studies.
There are several limitations to this study. Five of the 
included studies came from the same laboratory. Two of 
the included studies were investigating the placebo effect 
in patients, whereas the remaining 16 investigated placebo 
or nocebo effects in healthy volunteers. Additionally, the 
included studies investigated placebo or nocebo effects in 
several different symptoms (pain, nausea, cognitive per-
formance, mental distress, dopaminergic functioning, IBS 
symptoms, and side effects). Furthermore, although the 
placebo and nocebo effect often are defined as similar but 
opposing effects, producing, for example, opposite effects 
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Sex differences in the placebo and nocebo effects
that the results from the present review are not confounded. 
Another limitation is the small number of included stud-
ies, which may limit the generalizability of the findings. 
Moreover, most studies on the placebo and nocebo effect 
do not report on sex differences, possibly due to a lack of 
examining sex differences, or absence of sex differences. 
Consequently, there is a potential for negative or unreported 
data on sex differences in placebo and nocebo effects. Thus, 
the findings from the present study might be biased or under-
powered. It should also be noted that studies have reported 
that sex differences in pain reporting are due to the sex of 
the experimenter. However, although some journals require 
authors to report experimenter sex, none of the included 
studies in the present review investigated the contribution of 
the sex of the experimenter. To increase the understanding of 
the repeatedly observed sex differences in the placebo and 
the nocebo effect, it is suggested that future studies report 
on sex differences in the placebo and nocebo effect as well 
as the sex of the experimenter.
Conclusion
This study suggests that placebo responses are more often 
observed in males than in females, and that nocebo responses 
are more often observed in females than in males. Addition-
ally, verbally induced placebo responses are observed more 
often in males compared to females, whereas conditioned 
nocebo responses are observed more often in females com-
pared to males. The observed sex differences in placebo 
responding are probably due to larger stress reduction in males 
compared to females. The sex differences in nocebo respond-
ing may be explained by larger increases in stress and anxiety 
in females than in males. Furthermore, endogenous opioid 
transmission has been reported to be more effective in males 
compared to females and may, therefore, explain the observed 
sex differences in placebo analgesia and nocebo hyperalgesia.
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